In a report released today, James Edwardes Jones from RBC Capital maintained a Buy rating on Reckitt (RKT – Research Report), with a price ...

In a report released today, Dara Mohsenian from Morgan Stanley maintained a Hold rating on Kimberly Clark (KMB – Research Report), with a price ...

Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't ...

Bank stocks have been on a post-election upswing, with the KBW Nasdaq Bank Index ( ^BKX) up 14% since Trump won the ...

Issuance for next week falls to an estimated $5.151 billion, with $3.959 billion of negotiated deals and $1.193 billion of ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...

RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

Wells Fargo has recently reduced T-Mobile Us Inc (TMUS) stock to Equal Weight rating, as announced on January 6, 2025, according to Finviz. Earlier, on January 6, 2025, RBC Capital Mkts had reduced ...

Dyne Therapeutics Inc (DYN) stock saw a decline, ending the day at $14.13 which represents a decrease of $-0.64 or -4.33% from the prior close of $14.77. The stock opened at $14.89 and touched a low ...

Hedge funds have positioned for Donald Trump's U.S. presidency with their highest levels of borrowing since 2010, while ...

Inc. is well-positioned to challenge Carl Sagan's 1995 prophecy of a declining U.S. manufacturing sector, as the integration ...

U.S. stock-trading hedge funds kicked off the week with gross leverage levels in their highest range since 2010.